Copy to clipboard 
Two new studies indicate positive clinical outcomes using Exactech’s Equinoxe® shoulder preoperative Planning App and ExactechGPS® shoulder intraoperative navigation system.
For the first new study, Implications of Navigation System Use for Glenoid Component Placement in Reverse Shoulder Arthroplasty, authors researched the use of ExactechGPS for glenoid baseplate and screw placement with reverse total shoulder arthroplasty compared to conventional instrumentation. The study demonstrated that GPS navigation provided surgeons with greater control and helped them more accurately and precisely reproduce their preoperative plan.
The second paper, High Intraoperative Accuracy and Low Complication Rate for Computer Assisted Navigation of the Glenoid in Total Shoulder Arthroplasty, retrospectively analyzed 16,723 navigated cases with ExactechGPS and demonstrated that 98% of cases were completed as planned, with minimal deviation in glenoid version, glenoid inclination and glenoid positioning relative to the preoperative plan. The authors reported a very low complication rate associated with the use of the navigation system and concluded the system is safe and effective, with only 0.05% of patients experiencing coracoid bone fracture after tracker fixation.
Previous studies have also demonstrated that GPS provides verified placement accuracy within +/-2mm and 2 degrees of the preoperative plan, better glenoid fixation and improved two-year minimum clinical outcomes compared to non-navigated groups, including improved range of motion and reduced postoperative complications, revision rates and adverse events.
The GPS system was developed and is manufactured by Blue Ortho, an Exactech company. “We started Blue Ortho with the objective of providing a navigation system that truly makes a difference for surgeons and patients in arthroplasty,” said Anthony Boyer, Blue Ortho President and CEO. “We sought to design a system that was easy to use and seamlessly integrated with Exactech’s implants and instruments to offer the best possible surgeon experience. After 13 years of development and continuous improvement, we could not be more proud to see the level of adoption of this technology, where >40% of Exactech’s shoulders and >20% of Exactech’s knees are implanted worldwide using GPS navigation.”
Added Exactech’s Senior Vice President of Extremities, Chris Roche, “GPS is the first and only shoulder navigation technology that connects the preoperative plan with real-time intraoperative instrument guidance – and verifies implant placement.”
Source: Exactech
Two new studies indicate positive clinical outcomes using Exactech's Equinoxe® shoulder preoperative Planning App and ExactechGPS® shoulder intraoperative navigation system.
For the first new study, Implications of Navigation System Use for Glenoid Component Placement in Reverse Shoulder Arthroplasty, authors researched the use of ExactechGPS...
Two new studies indicate positive clinical outcomes using Exactech’s Equinoxe® shoulder preoperative Planning App and ExactechGPS® shoulder intraoperative navigation system.
For the first new study, Implications of Navigation System Use for Glenoid Component Placement in Reverse Shoulder Arthroplasty, authors researched the use of ExactechGPS for glenoid baseplate and screw placement with reverse total shoulder arthroplasty compared to conventional instrumentation. The study demonstrated that GPS navigation provided surgeons with greater control and helped them more accurately and precisely reproduce their preoperative plan.
The second paper, High Intraoperative Accuracy and Low Complication Rate for Computer Assisted Navigation of the Glenoid in Total Shoulder Arthroplasty, retrospectively analyzed 16,723 navigated cases with ExactechGPS and demonstrated that 98% of cases were completed as planned, with minimal deviation in glenoid version, glenoid inclination and glenoid positioning relative to the preoperative plan. The authors reported a very low complication rate associated with the use of the navigation system and concluded the system is safe and effective, with only 0.05% of patients experiencing coracoid bone fracture after tracker fixation.
Previous studies have also demonstrated that GPS provides verified placement accuracy within +/-2mm and 2 degrees of the preoperative plan, better glenoid fixation and improved two-year minimum clinical outcomes compared to non-navigated groups, including improved range of motion and reduced postoperative complications, revision rates and adverse events.
The GPS system was developed and is manufactured by Blue Ortho, an Exactech company. “We started Blue Ortho with the objective of providing a navigation system that truly makes a difference for surgeons and patients in arthroplasty,” said Anthony Boyer, Blue Ortho President and CEO. “We sought to design a system that was easy to use and seamlessly integrated with Exactech’s implants and instruments to offer the best possible surgeon experience. After 13 years of development and continuous improvement, we could not be more proud to see the level of adoption of this technology, where >40% of Exactech’s shoulders and >20% of Exactech’s knees are implanted worldwide using GPS navigation.”
Added Exactech’s Senior Vice President of Extremities, Chris Roche, “GPS is the first and only shoulder navigation technology that connects the preoperative plan with real-time intraoperative instrument guidance – and verifies implant placement.”
Source: Exactech
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
